North America Corneal Implants Market Size, Share & Industry Trends Analysis Report By Disease Type, By Procedure Type (Penetrating Keratoplasty, Endothelial Keratoplasty, and Others), By End User, By Country and Growth Forecast, 2023-2029

The North America Corneal Implants Market should witness market growth of 5.7% CAGR during the forecast period (2023-2029).

Bioengineered corneal implants are made using tissue engineering techniques to produce corneal implants from living cells. These implants may provide greater biocompatibility, a lower risk of problems, and better visual outcomes when compared to conventional synthetic implants.

Thus, the development of cutting-edge technologies is anticipated to fuel the expansion of the corneal implants market throughout the anticipated period. The market for corneal implants is also expected to grow due to rising demand for corneal transplants, better healthcare infrastructure, and prospects in developing nations. Also, there has been a huge increase in public knowledge of corneal transplantation, which spurs the market's expansion.

In the US, 4% of adults over the age of 40 have the late-onset variant of Fuchs endothelial dystrophy, which is a frequent disorder. The exact prevalence of the early-onset Fuchs endothelial dystrophy variety is yet unknown. However, for unknown reasons, women are two to four times more likely than men to develop Fuchs endothelial dystrophy. In addition, Fuchs endothelial dystrophy is uncertain in its genetics. The development of Fuchs endothelial dystrophy is thought to be influenced by various genes and areas found within a few chromosomes. Thus, these factors are propelling the market growth in the North America region.

The US market dominated the North America Corneal Implants Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $173.2 million by 2029. The Canada market is poised to grow at a CAGR of 8.2% during (2023-2029). Additionally, The Mexico market should witness a CAGR of 7.2% during (2023-2029).

Based on Disease Type, the market is segmented into Fuchs' Dystrophy, Keratoconus, Infectious Keratitis and Others. Based on Procedure Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, and Others. Based on End-user, the market is segmented into Hospitals, Ophthalmic Centers and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Presbia PLC, CorNeat Vision Ltd., Alcon, Inc., AJL Opthalmic SA, LinkoCare Life Sciences AB, CorneaGen, DIOPTEX GmbH, Mediphacos Industrias Medicas S.A., EyeYon Medical Ltd., and KeraMed, Inc.

Scope of the Study

By Disease Type

• Fuchs' Dystrophy
• Keratoconus
• Infectious Keratitis
• Others

By Procedure Type

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Others

By End-user

• Hospitals
• Ophthalmic Centers
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Presbia PLC
• CorNeat Vision Ltd.
• Alcon, Inc.
• AJL Opthalmic SA
• LinkoCare Life Sciences AB
• CorneaGen
• DIOPTEX GmbH
• Mediphacos Industrias Medicas S.A.
• EyeYon Medical Ltd.
• KeraMed, Inc.

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free